Stockreport

Bausch Health's new formulation of Xifaxan fails pair of Phase III trials [Yahoo! Finance]

Bausch Health Companies Inc.  (BHC) 
Last bausch health companies inc. earnings: 2/19 06:59 am Check Earnings Report
PDF The placebo-controlled trials evaluated the potential of amorphous-rifaximin solid soluble dispersion (SSD) to delay the onset of the first episode of HE in adults with [Read more]